Innovarx shutdown for ‘allegedly’ violating medicine regulations
The Medicines Control Agency closed Innovarx Global Health due to CEO Dr. Ismail Badjie’s noncompliance, including obstruction of inspectors and refusal to follow regulations regarding confiscated illegally imported medicines, citing public safety concerns. Dr. Badjie attributed the closure to arbitrary penalties and claimed targeted censure, underscoring broader regulatory challenges in The Gambia’s healthcare sector.